NCT07162883 2025-09-09
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
Qilu Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
Qilu Pharmaceutical Co., Ltd.
MegaPro Biomedical Co. Ltd.
RDO Pharm.